DZ2675A1 - Association pharmaceutique pour le traitement d'undysfunctionnement sexuel et compositions la conte nant. - Google Patents
Association pharmaceutique pour le traitement d'undysfunctionnement sexuel et compositions la conte nant.Info
- Publication number
- DZ2675A1 DZ2675A1 DZ980285A DZ980285A DZ2675A1 DZ 2675 A1 DZ2675 A1 DZ 2675A1 DZ 980285 A DZ980285 A DZ 980285A DZ 980285 A DZ980285 A DZ 980285A DZ 2675 A1 DZ2675 A1 DZ 2675A1
- Authority
- DZ
- Algeria
- Prior art keywords
- treatment
- compositions containing
- sexual dysfunction
- pharmaceutical association
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6974197P | 1997-12-16 | 1997-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ2675A1 true DZ2675A1 (fr) | 2003-03-29 |
Family
ID=22090927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ980285A DZ2675A1 (fr) | 1997-12-16 | 1998-12-15 | Association pharmaceutique pour le traitement d'undysfunctionnement sexuel et compositions la conte nant. |
Country Status (37)
Country | Link |
---|---|
EP (1) | EP1037616B1 (fr) |
JP (2) | JP2002508315A (fr) |
KR (1) | KR20010033092A (fr) |
CN (1) | CN1282248A (fr) |
AP (1) | AP915A (fr) |
AR (1) | AR016433A1 (fr) |
AT (1) | ATE318602T1 (fr) |
AU (1) | AU759825B2 (fr) |
BG (1) | BG104528A (fr) |
BR (1) | BR9813699A (fr) |
CA (1) | CA2314993A1 (fr) |
CO (1) | CO4810381A1 (fr) |
CZ (1) | CZ20002199A3 (fr) |
DE (1) | DE69833671T2 (fr) |
DZ (1) | DZ2675A1 (fr) |
EA (1) | EA200000526A1 (fr) |
ES (1) | ES2258300T3 (fr) |
GT (1) | GT199800177A (fr) |
HN (1) | HN1998000174A (fr) |
HR (1) | HRP20000407A2 (fr) |
HU (1) | HUP0100705A3 (fr) |
IL (1) | IL136515A0 (fr) |
IS (1) | IS5504A (fr) |
MA (1) | MA26586A1 (fr) |
NO (1) | NO20003065L (fr) |
NZ (1) | NZ504487A (fr) |
OA (1) | OA11423A (fr) |
PA (1) | PA8462801A1 (fr) |
PE (1) | PE20000011A1 (fr) |
PL (1) | PL341575A1 (fr) |
SK (1) | SK8782000A3 (fr) |
TN (1) | TNSN98227A1 (fr) |
TR (1) | TR200001733T2 (fr) |
UY (1) | UY25300A1 (fr) |
WO (1) | WO1999030697A2 (fr) |
YU (1) | YU33700A (fr) |
ZA (1) | ZA9811507B (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6469065B1 (en) | 1996-02-02 | 2002-10-22 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use |
US6331543B1 (en) | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
DE19844162A1 (de) * | 1998-09-25 | 2000-03-30 | Udo Dunzendorfer | Medikamentenkombinationen zur Therapie der erektilen Dysfunktion |
EP1161255A4 (fr) * | 1999-03-08 | 2002-07-17 | Merck & Co Inc | Procedes et compositions pour le traitement de la dyserection |
US7235625B2 (en) * | 1999-06-29 | 2007-06-26 | Palatin Technologies, Inc. | Multiple agent therapy for sexual dysfunction |
EP1200090B1 (fr) * | 1999-08-03 | 2013-09-11 | ICOS Corporation | Formulation pharmaceutique à base d'une béta-carboline et son utilisation pour traiter le dysfonctionnement sexuel |
TWI265925B (en) | 1999-10-11 | 2006-11-11 | Pfizer | Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them |
AU2000270300A1 (en) * | 2000-09-13 | 2002-03-26 | Isis Innovation Limited | Use of phosphodiesterase inhibitors for the treatment of anorectal disorders |
DE60113290D1 (de) * | 2000-11-17 | 2005-10-13 | Warner Lambert Co | Behandlung von sexueller funktionsstörung mit bombesin rezeptor antagonisten |
US20030114469A1 (en) * | 2001-09-27 | 2003-06-19 | Cohen David Saul | Combinations |
GB0219961D0 (en) | 2002-08-28 | 2002-10-02 | Pfizer Ltd | Oxytocin inhibitors |
GB0225908D0 (en) * | 2002-11-06 | 2002-12-11 | Pfizer Ltd | Treatment of female sexual dysfunction |
US7323462B2 (en) | 2002-12-10 | 2008-01-29 | Pfizer Inc. | Morpholine dopamine agonists |
CA2451267A1 (fr) | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Utilisations pharmaceutiques de ligands alpha2delta |
US7291640B2 (en) | 2003-09-22 | 2007-11-06 | Pfizer Inc. | Substituted triazole derivatives as oxytocin antagonists |
AP2007004047A0 (en) | 2005-01-20 | 2007-06-30 | Pfizer Ltd | Substituted triazole derivatives as oxtocin antagonists |
US8506934B2 (en) | 2005-04-29 | 2013-08-13 | Robert I. Henkin | Methods for detection of biological substances |
EP1956906A4 (fr) | 2005-11-09 | 2009-12-30 | Combinatorx Inc | Procedes, compositions et kits pour le traitement de pathologies |
WO2008095136A2 (fr) | 2007-01-31 | 2008-08-07 | Henkin Robert I | Procédés de détection de substances biologiques |
US8580801B2 (en) | 2008-07-23 | 2013-11-12 | Robert I. Henkin | Phosphodiesterase inhibitor treatment |
CN101781302B (zh) * | 2009-05-31 | 2013-07-10 | 段波 | 一种磷酸二酯酶抑制剂和异黄酮形成的加成物及其应用 |
EP2804603A1 (fr) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Composés promoteurs de réplication des cellules bêta et leurs procédés d'utilisation |
EP2903619B1 (fr) | 2012-10-05 | 2019-06-05 | Robert I. Henkin | Inhibiteurs de la phosphodiestérase destinés à traiter des troubles du goût et de l'odorat |
US10598672B2 (en) | 2014-02-18 | 2020-03-24 | Cyrano Therapeutics, Inc. | Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA878182B (en) * | 1986-11-05 | 1988-05-02 | Merrell Dow Pharmaceuticals Inc. | Enhancement of prazosin |
FR2649613B1 (fr) * | 1989-07-11 | 1991-09-27 | Virag Ronald | Medicament vaso-actif |
US5242391A (en) * | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
DK0459666T3 (da) * | 1990-05-31 | 1994-12-05 | Pfizer | Lægemidler mod impotens |
GB9311920D0 (en) * | 1993-06-09 | 1993-07-28 | Pfizer Ltd | Therapeutic agents |
GB9523752D0 (en) * | 1995-11-21 | 1996-01-24 | Pfizer Ltd | Pharmaceutical formulations |
-
1998
- 1998-10-29 AT AT98947741T patent/ATE318602T1/de not_active IP Right Cessation
- 1998-10-29 CZ CZ20002199A patent/CZ20002199A3/cs unknown
- 1998-10-29 IL IL13651598A patent/IL136515A0/xx unknown
- 1998-10-29 PL PL98341575A patent/PL341575A1/xx unknown
- 1998-10-29 CA CA002314993A patent/CA2314993A1/fr not_active Abandoned
- 1998-10-29 TR TR2000/01733T patent/TR200001733T2/xx unknown
- 1998-10-29 YU YU33700A patent/YU33700A/sh unknown
- 1998-10-29 EA EA200000526A patent/EA200000526A1/ru unknown
- 1998-10-29 NZ NZ504487A patent/NZ504487A/xx unknown
- 1998-10-29 EP EP98947741A patent/EP1037616B1/fr not_active Revoked
- 1998-10-29 KR KR1020007006455A patent/KR20010033092A/ko not_active Application Discontinuation
- 1998-10-29 HU HU0100705A patent/HUP0100705A3/hu unknown
- 1998-10-29 JP JP2000538680A patent/JP2002508315A/ja active Pending
- 1998-10-29 AU AU94558/98A patent/AU759825B2/en not_active Ceased
- 1998-10-29 BR BR9813699-2A patent/BR9813699A/pt not_active Application Discontinuation
- 1998-10-29 SK SK878-2000A patent/SK8782000A3/sk unknown
- 1998-10-29 CN CN98812331A patent/CN1282248A/zh active Pending
- 1998-10-29 ES ES98947741T patent/ES2258300T3/es not_active Expired - Lifetime
- 1998-10-29 WO PCT/IB1998/001723 patent/WO1999030697A2/fr active IP Right Grant
- 1998-10-29 DE DE69833671T patent/DE69833671T2/de not_active Expired - Fee Related
- 1998-11-09 GT GT199800177A patent/GT199800177A/es unknown
- 1998-11-10 PA PA19988462801A patent/PA8462801A1/es unknown
- 1998-11-11 HN HN1998000174A patent/HN1998000174A/es unknown
- 1998-11-30 CO CO98070722A patent/CO4810381A1/es unknown
- 1998-12-10 AP APAP/P/1998/001414A patent/AP915A/en active
- 1998-12-11 PE PE1998001206A patent/PE20000011A1/es not_active Application Discontinuation
- 1998-12-14 UY UY25300A patent/UY25300A1/es not_active Application Discontinuation
- 1998-12-15 ZA ZA9811507A patent/ZA9811507B/xx unknown
- 1998-12-15 MA MA25396A patent/MA26586A1/fr unknown
- 1998-12-15 DZ DZ980285A patent/DZ2675A1/fr active
- 1998-12-15 TN TNTNSN98227A patent/TNSN98227A1/fr unknown
- 1998-12-15 AR ARP980106360A patent/AR016433A1/es unknown
-
2000
- 2000-05-19 IS IS5504A patent/IS5504A/is unknown
- 2000-06-13 BG BG104528A patent/BG104528A/xx unknown
- 2000-06-15 NO NO20003065A patent/NO20003065L/no not_active Application Discontinuation
- 2000-06-15 OA OA1200000169A patent/OA11423A/en unknown
- 2000-06-16 HR HR20000407A patent/HRP20000407A2/hr not_active Application Discontinuation
-
2007
- 2007-08-20 JP JP2007213745A patent/JP2007332156A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ2675A1 (fr) | Association pharmaceutique pour le traitement d'undysfunctionnement sexuel et compositions la conte nant. | |
DZ2186A1 (fr) | Compositions pharmaceutiques mixtes pour le traitement de l'ostéoporose et procédé pour leur préparation. | |
MA26790A1 (fr) | Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie | |
MA26536A1 (fr) | Association de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation. | |
DZ2494A1 (fr) | Composition pharmaceutique d'oméprazole. | |
MA26889A1 (fr) | Composition pharmaceutique pour le traitement de la douleur aigue chronique et/ ou neuropathique et des migraines | |
DZ2752A1 (fr) | Composés et compositions pharmaceutiques pour le traitement du paludisme. | |
FR2732223B1 (fr) | Composition pharmaceutique pour administration transdermique | |
FR2729382B1 (fr) | Reacteur d'irradiation uv pour le traitement de liquides | |
DZ2596A1 (fr) | Associations pharmaceutiques d'amlodipine et d'atorvastatine et procédé pour leur préparation. | |
DZ2745A1 (fr) | BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
OA09123A (fr) | Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles. | |
DZ2600A1 (fr) | Associations pharmaceutiques d'amlodipine et d'unestatine et procédé pour leur préparation. | |
DZ3014A1 (fr) | Médicaments pour le traitement de l'hypertension. | |
MA26608A1 (fr) | Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque. | |
DE19580261D2 (de) | Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktion | |
DZ2539A1 (fr) | Compositions pharmaceutiques pour le traitement dela résistance à l'insuline. | |
MA25234A1 (fr) | Vibromasseur pour le soulagement des maux et de la douleur. | |
ZA968990B (en) | Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases. | |
FR2712495B1 (fr) | Application de l'Óoenotheine B pour obtenir un médicament destiné au traitement des troubles liés à l'hyperandrogénie, et les compositions pharmaceutiques le contenant. | |
FR2758465B1 (fr) | Composition pour le traitement de l'amiante | |
FR2752422B1 (fr) | Composition pharmaceutique contenant des acides 4-oxo-butanoiques | |
DZ2564A1 (fr) | Compositions pharmaceutiques pour le traitement dudiabète sucre et d'états associés. | |
FR2718024B1 (fr) | Médicament et composition pharmaceutique pour le traitement de l'inflammation. | |
MA23837A1 (fr) | Benzamides pour le traitement de degenerescenses neurologiques |